Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Antrim Pharmaceuticals LLC v. Bio-Pharm, Inc.
Case Number:
1:16-cv-00784
Court:
Nature of Suit:
Judge:
Firms
-
April 19, 2018
Bio-Pharm Must Face Generic-Drug Supply Contract Suit
Bio-Pharm Inc. must face a suit accusing the company of reneging on a drug supply agreement and holding generic medication "hostage" in order to gain a larger share of the profits than originally agreed upon, an Illinois federal judge ruled Thursday.
-
July 22, 2016
Drugmaker Can't Deny Contract, Then Sue Over It, Judge Told
Antrim Pharmaceuticals LLC told the Illinois federal judge overseeing its breach of contract suit against a contract drug manufacturer to block the manufacturer’s counterclaims, arguing it can't deny the contract and then use it to bring its own claims.
-
January 20, 2016
Manufacturer Holding Generic Lexapro 'Hostage,' Suit Claims
A contract drug manufacturer has reneged on its agreement with Antrim Pharmaceuticals LLC to supply a generic version of the antidepressant Lexapro by holding the medication "hostage" and demanding a larger share of the profits than agreed upon, according to a suit filed Tuesday in Illinois federal court.